Rasmussen syndrome
Rasmussen Syndrome is a rare, progressive, chronic encephalitis (inflammation of the brain) that typically affects only one hemisphere of the brain. It is most commonly seen in children under the age of 10, although adolescents and adults can also be affected.
Symptoms[edit]
The initial symptoms of Rasmussen Syndrome may include seizures, hemiparesis (weakness on one side of the body), and hemianopsia (loss of vision in one half of the visual field). As the disease progresses, it can lead to severe cognitive and physical impairments, including mental retardation and paralysis.
Causes[edit]
The exact cause of Rasmussen Syndrome is unknown. Some researchers believe it may be an autoimmune disease, while others suggest it could be caused by a viral infection.
Diagnosis[edit]
Rasmussen Syndrome is typically diagnosed based on the clinical symptoms, neuroimaging findings, and the progression of the disease. A brain biopsy may also be performed to confirm the diagnosis.
Treatment[edit]
There is currently no cure for Rasmussen Syndrome. Treatment is aimed at managing the symptoms and may include antiepileptic drugs to control seizures, physical therapy to manage hemiparesis, and corticosteroids to reduce inflammation. In severe cases, a surgical procedure called hemispherectomy may be performed to remove or disconnect the affected side of the brain.
Prognosis[edit]
The prognosis for individuals with Rasmussen Syndrome varies. Some individuals may have a relatively mild course of the disease, while others may experience severe cognitive and physical impairments.
See also[edit]
References[edit]
-
Rasmussen syndrome
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
